Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 6/29/2016 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Mary Rybak?

Mary Ellen Rybak

Vice President Gastrointestinal Malignancies

p53 Inc

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

p53 Inc

Background Information

Employment History

Healthcare Businesswomen's Association


Senior Consultant

Halozyme Therapeutics , Inc.


Chief Marketing Officer

Genitope Corporation


Vice President, Oncology

Johnson & Johnson


Various Research and Management Positions

Schering-Plough Corporation


Vice President, Oncology

Janssen L.P


Web References(26 Total References)


Dan Denney Email Genitope CEO CFO VP @genitope.com

www.lead411.com [cached]

Mary Rybak
Chief Marketing Officer and Vice President Clinical Affairs


Dan Denney Email Genitope CEO CFO VP @genitope.com

www.lead411.com [cached]

Mary Rybak [VCard] VP Medical Affairs/Chief Medical Officer


Genitope - Executive Management

www.genitope.com [cached]

Michael J. Buckley, Ph.D. | Thomas DeZao | Claude Miller | David Miller | Mary Ellen Rybak, M.D. | Thomas Theriault, Ph.D. | John Vuko | Laura WoodheadMary Ellen Rybak, M.D., Chief Medical Officer and Vice President of Medical AffairsMary Ellen Rybak, M.D.Chief Medical Officer and Vice President of Medical AffairsMary Ellen Rybak, M.D. has served as our Vice President of Medical Affairs since May 2006.Prior to joining Genitope Corporation, Dr. Rybak was Vice President of Oncology at Johnson & Johnson Pharmaceutical Research and Development (Johnson & Johnson PRD; formerly Janssen Research Foundation), where she oversaw the initial development of the company's therapeutic oncology unit.She has extensive experience in oncology clinical trial management and led the team that submitted Johnson & Johnson PRD's first NDA for an internally discovered new chemical entity.Previously, Dr. Rybak held various research and management positions at Schering Plough Research Institute (Union, New Jersey), and a number of academic and administrative positions at University of Massachusetts Medical School.


www.genitope.com

Mary Ellen Rybak, M.D., Chief Medical Officer and Vice President of Medical AffairsMary Ellen Rybak, M.D.Chief Medical Officer and Vice President of Medical AffairsMary Ellen Rybak, M.D. has served as our Vice President of Medical Affairs since May 2006.Prior to joining Genitope Corporation, Dr. Rybak was Vice President of Oncology at Johnson & Johnson Pharmaceutical Research and Development (Johnson & Johnson PRD; formerly Janssen Research Foundation), where she oversaw the initial development of the company's therapeutic oncology unit.She has extensive experience in oncology clinical trial management and led the team that submitted Johnson & Johnson PRD's first NDA for an internally discovered new chemical entity.Previously, Dr. Rybak held various research and management positions at Schering Plough Research Institute (Union, New Jersey), and a number of academic and administrative positions at University of Massachusetts Medical School.


www.sec.gov

Mary Ellen Rybak, M.D.(13) Includes 47,500 shares that Dr. Rybak has the right to acquire within 60 days of January 15, 2008 through the exercise of stock options.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory